Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 463 of 1,261
  1. US 10463028

    Genetically modified non-human animals expressing human EPO

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  2. US 10464967

    Non-hormonal steroid modulators of NF-κβ for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  3. US 10463749

    Maytansinoid derivatives, conjugates thereof, and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  4. US 10464739

    Reduction in stress cracking of films

    Aquestive Therapeutics, Inc. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  5. US 10463745

    Materials for tissue regeneration

    Northwestern University · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  6. US 10463029

    Rodent model of steel syndrome

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  7. US 10464941

    Therapeutic compounds

    Regents of the University of Minnesota · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  8. US 10464918

    Process of making somatostatin modulators

    CRINETICS PHARMACEUTICALS, INC. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  9. US 10463744

    Polymer-semaxanib moiety conjugates

    Nektar Therapeutics · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  10. US 10463734

    Nanoparticle therapy in cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  11. US 10463718

    Adeno-associated virus factor VIII vectors

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  12. US 10463733

    Ultra-stable protein ionic liquids

    United States of America as represented by the Secretary of the Air Force · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  13. US 10463685

    Telomerase mediated telomere altering compounds

    The Board of Regents of the University of Texas System · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  14. US 10466259

    Synthetic antigen compositions for detecting anti-phosphatidylethanolamine antibodies

    Northwestern University · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted
  15. CA 3097885

    PROCEDES ET COMPOSITIONS D'EPUISEMENT DE LYMPHOCYTES T CYTOTOXIQUES

    CRISPR THERAPEUTICS AG [CH] · Granted Oct 31, 2019 · Expires Oct 26, 2039

    granted
  16. CA 3098014

    CELLULES CAR-T ANTI-BCMA POUR DEPLETION DE CELLULES PLASMATIQUES

    CRISPR THERAPEUTICS AG [CH] · Granted Oct 31, 2019 · Expires Oct 26, 2039

    granted
  17. US 10457670

    Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease

    Takeda Pharmaceutical Company Limited · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  18. US 10457703

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  19. US 10456448

    PTD-SMAD7 therapeutics

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  20. US 10456373

    Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon

    OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM” · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  21. US 10456390

    Combinations comprising MABA compounds and corticosteroids

    Almirall, S.A. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  22. US 10456439

    NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation

    ACADEMISCH MEDISCH CENTRUM · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  23. US 10456476

    Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  24. US 10457654

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.